Atlas Trials

Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy

Clinical trial NCT03017794 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03017794
Sponsor
Mayo Clinic
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2017-01-04
Primary completion
2027-12-31
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.